Penicillin is a bactericidal antibiotic that inhibits the synthesis of the peptidoglycan by targeting penicillin-binding proteins. This study aimed to assess through transcriptional profiling the stress response of S. pneumoniae strains after exposure to lethal penicillin concentrations to understand further the mode of action of penicillin. Two experimental designs (time-course and dose-response) were used for monitoring the effect of penicillin on the transcriptional profile. The expression of some genes previously shown to be modulated by penicillin was altered, including ciaRH, pstS and clpL. Genes of the glnRA and glnPQ operons were among the most downregulated genes in the three strains. These genes are involved in glutamine synthesis and uptake and LC-MS work confirmed that penicillin treatment increases the intracellular glutamine concentrations. Glutamine conferred a protective role against penicillin when added to the culture medium. Glutamine synthetase encoded by glnA catalyses the transformation of glutamate and ammonium into glutamine and its chemical inhibition by the inhibitor L-methionine sulfoximine is shown to sensitize S. pneumoniae to penicillin, including penicillin-resistant clinical isolates. In summary, a combination of RNA-seq and metabolomics revealed that penicillin interferes with glutamine metabolism suggesting strategies that could eventually be exploited for combination therapy or for reversal of resistance.
. Genes modulated by PEN in S. pneumoniae R6 in the time-course transcriptomic design. a PEN was added at 1 X MIC at T0 and the differential gene expression was tested for three time points (T1, T2 and T3). Genes included showed significant variations of log 2 FC ≤ −1 or log 2 FC ≥ +1 with a q-value ≤ 0.05. b '-' means no significant change in expression. c 'No PEN' corresponds to the genes modulated in the untreated R6. d 'PEN' corresponds to the genes modulated in the treated R6. e Genes involved in glutamine metabolism are shown in bold.
SCIentIFIC REPORTS | 7: 14587 | DOI:10.1038/s41598-017-15035-y pneumoniae R6 was grown in BHI medium supplemented with glutamine at 0, 6 and 12 mM at early log-phase, half an hour before the addition of PEN at 1X MIC ( Supplementary Fig. S2a ). The survival rates at 30 min and 60 min were derived from the ratio of bacterial counts in the presence of PEN compared to untreated bacteria at each time point. Interestingly, glutamine at 6 mM and 12 mM conferred considerable protection against PEN by increasing survival rates at 30 min from 40% to 60% and from 40% to 75%, respectively ( Fig. 3a ). Survival rates also increased from 5% to 11% at 60 min in the presence of glutamine (Fig. 3a ). The protection conferred by glutamine supplementation was specific to PEN and was not observed with ciprofloxacin (CIP), a fluoroquinolone antibiotic inhibiting DNA replication ( Fig. 3b & Supplementary Fig. S2b ). In fact in the case of CIP, glutamine at 6 mM or 12 mM was detrimental and apparently enhanced its lethality by decreasing survival rates from 60% to 38% and from 20% to 5% at 30 and 60 min, respectively ( Fig. 3b ).
Inhibiting the glutamine synthetase GlnA renders S. pneumoniae more susceptible to penicillin. Because glutamine supplementation decreased susceptibility to PEN, we next sought whether inhibiting the glutamine synthetase GlnA would enhance PEN lethality. The MIC of PEN against S. pneumoniae R6 was determined in the presence of L-methionine sulfoximine (MSO), a specific inhibitor of GlnA [28] [29] [30] . Attempts to determine the toxicity of MSO in S. pneumoniae were not possible by microdilution and bacteria were growing albeit at a lesser density up to 32 mM by macrodilution. The larger culture volume of macrodilution (see Methods) facilitated measurements. Several concentrations of MSO were tested in combination with PEN, and 0.5 mM MSO was found to have maximal effect on PEN susceptibility while alone having minimal activity against S. pneumoniae. Indeed, 0.5 mM MSO increased the susceptibility of S. pneumoniae R6 to PEN by four-fold, from a MIC of 0.03 µg/mL in the absence of MSO to a MIC of 0.008 µg/mL ( Table 4 ). Addition of glutamine at 12 mM completely reverted this PEN hyper-susceptibility phenotype (Table 4 ). A two-to four-fold sensitization to PEN induced by MSO was also observed in the PEN-susceptible S. pneumoniae clinical isolates CCRI-21487 and CCRI-8970, but also in PEN-resistant clinical isolates (CCRI-1397, CCRI-1414 and CCRI-1983) ( Table 4 ). Again, glutamine fully (or partially in the case of CCRI-1983) rescued the hyper-susceptibility phenotype (Table 4 ).
Discussion
Gene expression modulation is central to bacterial adaptation and can mirror the cellular response to stress-induced damages. In this study, we used RNA-seq to assess the metabolic consequences of exposure to PEN in S. pneumoniae. A number of genes previously shown to be implicated in PEN resistance were detected, including ciaRH 19 , pstS 19,31 and clpL 32, 33 . The transcriptional regulator CiaR was previously shown to influence on natural competence and susceptibility to β-lactams in S. pneumoniae 34 . It is known to activate fourteen promoters 35 and many of the genes under its control had indeed increased expression in the presence of PEN, such as the foldase prsA, the acetyl xylan esterase axe1, the maltodextrin phosphorylase malP, the serine protease htrA, the chromosome segregation protein spoOJ and the hypothetical protein coding genes spr0782 and spr0931 (Table 1) . CiaR also drives the expression of small regulatory non-coding RNAs 36 and one target of such RNA (the formate/nitrate transporter nirC) was found to be overexpressed (Table 1) . Apart from the CiaRH regulon, adenylate kinase, glutathione S-transferase, the fatty acid and phospholipid-related genes fabK, fabG, fabF, fabZ and accD and a gene from the MutT/nudix family whose expression was decreased in our RNA-seq data had previously been shown to be downregulated by PEN using microarrays 19 , so is the case for the overexpression of LysM domain-containing proteins and molecular chaperones (Tables 1 & 2) . Common to all S. pneumoniae strains and transcriptomics designs was the downregulation of the glnRA and glnPQ operons ( Table 3 ). The transcriptional regulator glnR mediates the repression of its own glnRA operon, the glnPQ-zwf operon and the gdhA gene by binding to a conserved operator sequence 37 . The gene glnA encodes glutamine synthetase which is responsible for the conversion of glutamate and ammonium into glutamine 37 . GlnA also indirectly influences the transcription of its own operon by stimulating the binding of GlnR. The glnPQ genes are coding for a transporter involved in glutamine scavenging 37 . Targeted metabolomics using LC-MS revealed an increase in glutamine concentrations following exposure to PEN in all three S. pneumoniae strains studied (Fig. 2) . The increase is considerable with 4-to-20 fold increase compared to the untreated cells control. Since high concentration of glutamine down-regulates the glnRA and glnPQ operons 37, 38 , the decreased expression of those two operons (Table 3 ) are most likely due to the penicillin-induced increase in glutamine levels (Fig. 2) . Glutamate levels increased moderately (2-4 fold) in the S. pneumoniae R6, CCRI-21487 and CCRI-8970 when compared to untreated cells at the same time point (Fig. 2) . Intriguingly, glutamine levels were increased two-fold in R6 during growth ( Fig. 2a) but not in the two other strains. One possible candidate is glnH (spr0534) coding for an ABC transporter that binds glutamine and glutamate 39 . Indeed, glnH remained constant in R6 untreated cells but downregulated in untreated CCRI-8970 and CCRI-21487 (Tables S1 and S2). These RNA seq data were confirmed by qRT-PCR ( Supplementary Fig. S3 ). Upon penicillin treatment, glnH is downregulated in the two clinical isolates but upregulated in R6 ( Supplementary Fig. S3 ). This differential expression of glnH in R6 may contribute to the higher uptake and accumulation of glutamate and glutamine observed in R6 (Fig. 2) .
The mechanism by which PEN increases the levels of glutamine is still unclear. However, glutamine is a major nitrogen donor for the synthesis of cell building blocks and is used by the aminotransferase GlmS to convert fructose-6-phosphate into glucosamine-6-phosphate (Glc-6P) 40 . GlmS occupies a central position between glycolysis and peptidoglycan synthesis in catalysing the first of a series of reactions leading to the cell wall precursor UDP-N-acetylglucosamine 40 . Inactivation or chemical inhibition of GlmS was shown to synergize with a broad set of cell wall synthesis inhibitors in Staphylococcus aureus 41, 42 . Similarly, disruption of the downstream phosphoglucosamine mutase GlmM increased the susceptibility of Streptococcus gordonii to PEN 43 in addition to decrease methicillin resistance in S. aureus without affecting the production of endogenous PBPs [44] [45] [46] 47 . Consistent with these findings, here we observed that the inhibition of GlnA leads to penicillin sensitization in S. pneumoniae clinical isolates (Table 4 ). Chemical inhibition of GlmS in methicillin-resistant S. aureus 42 and of GlnA in PEN-resistant S. pneumoniae clinical isolates (Table 4) decreased their levels of resistance. Conversely, the mere addition of glutamine was found to be partly protective against the action of penicillin ( Fig. 3) . Glutamine is also a co-factor for the amidation of the second amino acid residue of lipid II by MurT/GatD, which is required for efficient cross-linking of the peptidoglycan 48 . It remains to be established whether glutamine accumulation is a secondary response from bacteria to PEN attack against the peptidoglycan assembly machinery or if the role of PEN is more direct, for example by hampering the use of glutamine by GlmS or by MurT/GatD. Additional work may shed further light on this.
In an era of ever increasing antibiotic resistance and shortage of new molecules, new strategies are required for increasing the activity of current antibiotics against sensitive and resistant bacteria. Our study showed a new link between glutamine metabolism and PEN susceptibility. The search for antibiotic adjuvants is now an intensive field of investigations 8 . Metabolites are now emerging as possible adjuvants and one possible strategy is the inhibition of metabolic pathways. For example exogenous alanine was shown to revert kanamycin resistance in a number of bacterial species 49 and tetracycline resistance and thiamine biosynthesis were linked in S. pneumoniae 25 while bacterial resistance to tetracycline can be reversed using tryptophan analogues 50 . Further investigations are warranted in the attempt of restoring PEN activity using strategies to lower cellular glutamine levels. For example, untargeted metabolomics experiments may help elucidating the mechanism by which PEN leads to cell death by revealing the extent of metabolic alterations associated with it. This may have added benefits as glutamine was also shown to be involved in virulence, and deletion of glnA and glnP led to attenuated colonization 38 and to decreased bloodstream invasiveness and survival in the lungs 38 , respectively. While still speculative, interfering with the metabolism of glutamine such as inhibiting GlnA would increase PEN susceptibility but also reduces virulence and drug-like leads against this target may thus serve dual purposes when paired with existing β-lactam antibiotics. Table 2 . Genes modulated by PEN in S. pneumoniae R6 in the dose-response transcriptomic design. a Genes underlined are common between Table 1 and Table 2 . b Penicillin (PEN) was added at 0.5, 1, 5 and 10X MIC at T0 and the differential gene expression was tested between 15 min and T0. Genes included showed significant variations of log 2 FC ≤ −1 or log 2 FC ≥ +1 with a q-value ≤0.05. c '−' means no significant change in expression. d 'No PEN' corresponds to the genes modulated in the untreated R6. e Genes involved in glutamine metabolism are shown in bold.
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Methods
Bacterial strains and growth conditions. S. pneumoniae strains were grown in brain heart infusion broth (BHI, Becton Dickinson), or in blood agar containing 5% defibrinated sheep's blood (Becton Dickinson). Cultures were incubated for 16 to 24 hours in a 5% CO 2 atmosphere at 35 °C as previously described 51 . All strains were maintained frozen at −80 °C in BHI containing 15% glycerol. For the RNA-seq experiments, S. pneumoniae was grown in BHI broth at 35 °C until early log-phase (OD 600 = 0.11). At this time (T0), cultures were divided into 18 tubes for the time-course design, half of which contained 1 X MIC PEN and incubated until survival rates of 95-75% (T1), 75-60% (T2) and 60-40% (T3) (6 tubes each Macrodilution was performed in triplicate in a volume of 3 ml in CAMHB or CAMHB supplemented with 12 mM glutamine. S. pneumoniae inoculum were prepared by suspending colonies grown overnight on TSA agar (Becton Dickinson) using 1× PBS to achieve a turbidity of 0.5 McFarland (1 × 10 8 CFU/ml). Fifteen microliters of this suspension was inoculated to the CAMBH broth to reach a concentration of 5 × 10 5 CFU/mL. MICs of PEN were determined in the presence or absence of varying concentrations (0.008 to 32 mM) of L-methionine sulfoximine (MSO; Sigma-Aldrich) but 0.5 mM was the lowest MSO concentration to allow maximal effects on the MIC of PEN. For sensitive strains, the range of PEN concentrations tested varied between 0.004 and 0.12 µg/ mL in doubling dilutions. For resistant isolates this varied from 0.06 to 8 µg/mL. Tubes were incubated at 35 °C and turbidity was checked after 20-24 h. T1/T0 T2/T0 T3/T0 T1/T0 T2/T0 T3/T0 T1/T0 T2/T0 T3/ Table 3 . Genes modulated in a common fashion by PEN in S. pneumoniae R6, CCRI-8970 and CCRI-21487. a Penicillin (PEN) at 1 X MIC was added at T0 and the differential gene expression was tested for three time points (T1, T2 and T3). Genes included showed significant variations of log 2 Quantitative reverse transcription (qRT-PCR). The qRT-PCR experiment was done as previously described 25 . Briefly, total RNAs were extracted as described above and treated with DNase I (Ambion) to avoid any DNA contamination. RNA quality and integrity was assessed by agarose gel electrophoresis. cDNAs were generated from 50 ng of total RNA using the Superscript II reverse transcriptase (Invitrogen) and random hexamers according to the manufacturer's instructions. qRT-PCR assays were carried out on a Bio-Rad Cycler using SYBR Green I. A final volume of 10 µl was used for each reaction containing specific primers (Table S4 ) and iQ SYBR Green Supermix (Bio-Rad). The relative quantitation of gene expression was performed using the relative standard curve method. All qRT-PCR data were normalized according to the amplification signals of 16S rRNA.
Entry no. in R6 genome database Gene Symbol Gene description Condition
Metabolites extraction. S. pneumoniae strains were grown in BHI broth at 35 °C until they reached early log-phase (OD 600 = 0.11). At this time (T0), cultures were divided into 6 tubes of 10 mL, half of which contained 1X MIC PEN, and incubated for a duration equivalent to time point T3 of the time-course RNA-seq experiments. Samples were rapidly quenched by submersion into dry ice/ethanol for 20 sec. The quenched samples were centrifuged at 1500 RCF for 10 min at 4 °C then washed twice with ice-cold PBS 1× and centrifuged for 5 min at 4 °C . Pellets were flash frozen in liquid nitrogen before being stored at −80 °C until use. Cell lysis and protein denaturation was achieved by addition of 200 µL of cooled methanol: water (4:1) supplemented with a mixture of deuterated glutamine and glutamate standards (at 300 and 500 ng/mL respectively) along with 100 mg acid washed glass beads (≤106 µm, Sigma) to the pellets followed by agitation in a bead beater at 4 °C for 6 cycles of 1 min agitation and 1 min cooling (Mini-BeadBeater-24, BioSpec Products, Inc.). Samples were then centrifuged at 13000 rpm for 5 min at 4 °C . Supernatant (150 µL) were speed-vac dried for 65 min at medium heat. Lyophilised samples were kept at −80 °C until further analysis. The LC-MS data were normalized according to the bacterial count obtained by plating on Trypticase soy agar supplemented with 5% sheep blood (BD).
LC-MS.
Lyophilised samples were resuspended in 150 µL of 50:50 of mobile phase A: mobile phase B (MPA: MPB), sonicated 5 min and filtrated on a 0.45 µm filter before injection. Liquid chromatography was performed on an Acquity UPLC I-Class binary pump system. The MPA consisted of 0.1% formic acid in water and the MPB consisted of 0.1% formic acid in acetonitrile. The column used was a BEH Amide 1.7 µM × 2.1 mm × 150 mm (Waters Corporation, part no. 186004802) at 45 °C . A VanGuard pre-column with 2.1 × 5 mm filter unit (Waters corporation, part no 205000343) was used to protect the analytical column from impurities. Gradient conditions were: 0.01 to 0.1 min = 99% B; 0.1 to 7.00 min = 99 to 50% B; 7.00 to 7.10 min = 50% to 99% B; 7.10 to 10.00 min = 99% B. Injection volume was 2.0 µL, and flow rate was 0.4 mL/min. Single reaction monitoring (SRM) analysis were performed on a Q-TOF Synapt G2-Si system with an electrospray ionization source (ESI) in positive ionization mode. Source conditions and MS parameters were optimized by direct infusion of standards in sensitivity mode. MS parameters included: capillary voltage 2.75 kV, source temperature 120 °C , desolvation temperature 325 °C and desolvation gas 900 L*min −1 . The specific SRM transitions for quantification were: 
Statistical analysis. Statistical analysis for the qRT-PCR experiment was done using a split plot design and
Fisher's F-test using the SAS software. Significant differences in the LC-MS quantification of glutamine and glutamate and in survival rates in the presence of glutamine were determined using unpaired (two-tailed) Student's t test in GraphPad Prism. Comparative data with a p value ≤ 0.05 were considered statistically different.
